[No data.]
Example of SummaryOfNetEffect Profile of Composition Resource.
StudyEligibilityCriteria: Eligibility Criteria for Bariatric Surgery Randomized Trial (Diabetes Surgery Study)
EvidenceReportSubject: Clinical Outcomes for Effects of Bariatric Surgery
SummaryOfNetEffect: Bariatric Surgery Summary of Net Effect Contributions Example for GIN 2022
SummaryOfNetEffect: Bariatric Surgery Summary of Net Effect Contributions Example for GIN 2022 [Database Entry: FHIR Composition Resource]. Contributors: Brian S. Alper [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 104383. Revised 2026-01-22. Available at: https://fevir.net/resources/Composition/104383. Computable resource at: https://fevir.net/resources/Composition/104383#json.
Net Effect Screenshot 2025-03-07 111436.jpg
Introduction (Source) for Net Benefit Calculator
The evidence to estimate the benefits and harms comes from observational studies (https://academic.oup.com/eurheartj/article/43/20/1955/6542137, https://jamanetwork.com/journals/jama/fullarticle/1103994, https://jamanetwork.com/journals/jama/fullarticle/2669729).
Introduction (For Whom) for Net Benefit Calculator
The estimated benefits and harms are for adults who are obese and have diabetes.
Introduction (What) for Net Benefit Calculator
This Net Benefit Calculator is prepared to help you decide whether or not to have a surgery on your stomach to help you lose weight.
Outcome
Desirability
Relative Importance
Result without bariatric surgery
Result with intervention alone (calculated)
calculated value derived from the control group and effect estimate
Result with bariatric surgery (calculated)
Effect Estimate (Absolute Difference)
Health Impact (Confidence Interval)
[No narrative text.]
Summary of net effect contributions entry for a single outcome
DichotomousIntendedOutcome: Remission of diabetes
Remission of diabetes
Desirable
Outcome Importance Rating of DichotomousIntendedOutcome: Remission of diabetes for StudyEligibilityCriteria: Eligibility Criteria for Bariatric Surgery Randomized Trial (Diabetes Surgery Study)
15%
ComparatorOnlyEvidence: Remission of diabetes without bariatric surgery (Control Group) in JAMA 2018 Norwegian cohort study
ComparativeEvidence: Bypass surgery effects on Remission of diabetes in JAMA 2018 Norwegian cohort study
6.44 (4 to 9.77)
NetEffectContribution: Remission of diabetes for Example for GIN 2022
Mortality
Undesirable
Outcome Importance Rating of Mortality for Bariatric Surgery Patients
100%
ComparatorOnlyEvidence: All-cause mortality without bariatric surgery in 2022 meta-analysis
ComparativeEvidence: All-cause mortality effect of bariatric surgery in 2022 meta-analysis
2.14 (1.8 to 2.42)
NetEffectContribution: All-cause mortality for Example for GIN 2022
Nonfatal myocardial infarction or stroke
DichotomousIntendedOutcome: Nonfatal myocardial infarction or stroke
Outcome Importance Rating of DichotomousIntendedOutcome: Nonfatal myocardial infarction or stroke for StudyEligibilityCriteria: Eligibility Criteria for Bariatric Surgery Randomized Trial (Diabetes Surgery Study)
50%
9.2%
ComparatorOnlyEvidence: Myocardial infarction or stroke without bariatric surgery (Control Group) in Swedish Obese Subjects (SOS) study
ComparativeEvidence: Bypass surgery effects on Myocardial infarction or stroke in Swedish Obese Subjects (SOS) study
1.52 (0.78 to 2.12)
NetEffectContribution: Nonfatal myocardial infarction or stroke for Example for GIN 2022
DichotomousIntendedOutcome: Treatment with opioids
Treatment with opioids
Outcome Importance Rating of DichotomousIntendedOutcome: Treatment with opioids for StudyEligibilityCriteria: Eligibility Criteria for Bariatric Surgery Randomized Trial (Diabetes Surgery Study)
ComparatorOnlyEvidence: Treatment with opioids without bariatric surgery (Control Group) in JAMA 2018 Norwegian cohort study
ComparativeEvidence: Bypass surgery effects on Treatment with opioids in JAMA 2018 Norwegian cohort study
-0.71 (-0.95 to -0.47)
NetEffectContribution: Treatment with opioids for Example for GIN 2022
DichotomousIntendedOutcome: New onset depression
New onset depression
Outcome Importance Rating of DichotomousIntendedOutcome: New onset depression for StudyEligibilityCriteria: Eligibility Criteria for Bariatric Surgery Randomized Trial (Diabetes Surgery Study)
25%
6.5%
ComparatorOnlyEvidence: New onset depression without bariatric surgery (Control Group) in JAMA 2018 Norwegian cohort study
ComparativeEvidence: Bypass surgery effects on New onset depression in JAMA 2018 Norwegian cohort study
-0.81 (-1.14 to -0.65)
NetEffectContribution: New onset depression for Example for GIN 2022
Additional gastrointestinal surgical procedure
DichotomousIntendedOutcome: Additional gastrointestinal surgical procedure
Outcome Importance Rating of DichotomousIntendedOutcome: Additional gastrointestinal surgical procedure for StudyEligibilityCriteria: Eligibility Criteria for Bariatric Surgery Randomized Trial (Diabetes Surgery Study)
ComparatorOnlyEvidence: Additional GI surgical procedure without bariatric surgery (Control Group) in JAMA 2018 Norwegian cohort study
31%
ComparativeEvidence: Bypass surgery effects on Additional GI surgical procedure in JAMA 2018 Norwegian cohort study
-3.88 (-5.42 to -2.71)
NetEffectContribution: Additional GI surgical procedure for Example for GIN 2022
4.7 (1.4 to 7.99)
NetEffectEstimate for SummaryOfNetEffect: Bariatric Surgery Summary of Net Effect Contributions Example for GIN 2022